CytoSorbents posts flat Q4 revenue of $9.2 million, plans FDA filing
Go back to CytoSorbents posts flat Q4 revenue of $9.2 million, plans FDA filing| Cytosorbents Corporation (NASDAQ: CTSO) | Delayed: 0.40 +0.04 (11.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.36 | 52 Week High | $7.48 | |||
| Open | $0.36 | 52 Week Low | $3.11 | |||
| Day High | $0.40 | P/E | N/A | |||
| Day Low | $0.36 | EPS | $-0.03 | |||
| Volume | 54,975 | |||||
